Table 2.
Performance characteristics of the optimized method.
| Component | Liner range (μg∙L−1) | Linear equation | R2 | LODs (μg∙kg−1) | LOQs (μg∙kg−1) |
|---|---|---|---|---|---|
| Penconazol | 0.1 ∼ 20 | y = 51241.219x + 4657.366 | 0.9997 | 0.10 | 0.30 |
| Myclobutanil | 0.1 ∼ 20 | y = 49946.485x + 10999.694 | 0.9988 | 0.12 | 0.36 |
| Cyproconazol | 0.1 ∼ 20 | y = 231859.640x + 20885.882 | 0.9997 | 0.10 | 0.30 |
| Uniconazole | 0.1 ∼ 20 | y = 75514.179x-2658.992 | 0.9998 | 0.10 | 0.30 |
| Flusilazole | 0.1 ∼ 20 | y = 150500.045x + 33920.103 | 0.9986 | 0.10 | 0.30 |
| Triadimefon | 0.1 ∼ 20 | y = 9186.544x-58.922 | 0.9999 | 0.25 | 0.75 |
| Triadimenol | 0.1 ∼ 20 | y = 10548.999x-1440.487 | 0.9978 | 0.10 | 0.30 |
| Flutriafol | 0.1 ∼ 20 | y = 143432.663x + 6767.538 | 0.9999 | 0.20 | 0.60 |
| Fluconazole | 0.1 ∼ 20 | y = 19019.655x-1637.019 | 0.9979 | 0.30 | 0.90 |
| Tebuconazole | 0.1 ∼ 20 | y = 86025.172–18847.003 | 0.9984 | 0.12 | 0.36 |
| Hexaconazole | 0.1 ∼ 20 | y = 80443.484x + 21374.976 | 0.9958 | 0.25 | 0.75 |
| Simeconazole | 0.1 ∼ 20 | y = 127044.023x + 7315.056 | 0.9998 | 0.30 | 0.90 |
| Triticonazole | 0.1 ∼ 20 | y = 58175.053x + 5183.091 | 0.9998 | 0.10 | 0.30 |
| Diniconazole | 0.1 ∼ 20 | y = 44277.822x + 9612.066 | 0.9989 | 0.30 | 0.90 |
| Epoxiconazol | 0.1 ∼ 20 | y = 217013.767x + 23351.808 | 0.9998 | 0.20 | 0.60 |
| Fenbuconazole | 0.1 ∼ 20 | y = 22225.999x-2054.964 | 0.9979 | 0.30 | 0.90 |
| Propiconazole | 0.1 ∼ 20 | y = 23542.032x-1778.438 | 0.9991 | 0.30 | 0.90 |
| Voriconazole | 0.1 ∼ 20 | y = 111956.515x-11848.615 | 0.9986 | 0.30 | 0.90 |
| Tetraconazole | 0.1 ∼ 20 | y = 179184.865x + 6612.699 | 0.9999 | 0.25 | 0.75 |
| Bromuconazole | 0.1 ∼ 20 | y = 169251.769x + 46909.206 | 0.9976 | 0.30 | 0.90 |
| Difenoconazole | 0.1 ∼ 20 | y = 410692.980x-21715.252 | 0.9996 | 0.25 | 0.75 |